Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Swarmer Reports First Quarter Financial Results
-
Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update
-
ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026
-
AirJoule Technologies Schedules Release of First Quarter 2026 Results and Conference Call
-
Esperion Announces Two New Analyses Supporting Bempedoic Acid to Reduce LDL-C Levels to be Presented at the European Atherosclerosis Society (EAS) Congress 2026
-
ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial
-
Arcanis Publishes Twin Research Papers Calling 'Bloomberg Moment' for Late-Stage Private Markets
-
Dr. Jonathan Gavras Joins Healthmap Solutions as Chief Medical Officer
-
Quantum Cyber N.V. Secures Exclusive Autonomous Drone Platform as Trump Administration Seeks $55 Billion for Drone Warfare
-
Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center
-
LexisNexis Expands Lexis+ with Protégé by Integrating Anthropic’s Claude Legal Plugin Suite
-
Allegro MicroSystems to Present at TD Cowen’s 54th Annual Technology, Media & Telecom Conference on Wednesday, May 27, 2026
-
Enphase Energy Opens U.S. Pre-Orders for GaN-Based 548 VA IQ9S Commercial Microinverters
-
Diginex Appoints Archana Kotecha as Chief Impact Officer to Advance Human Rights and Scale Supply Chain Solutions in a $9.6B Market
-
Gildan Announces the Publication of its 2025 Sustainability Report Highlighting Continued Progress Towards Key Social and Environmental Targets¹
-
Nuataaq Carabiner Bottle Awarded “Water Bottle Product of the Year” By Outdoor Innovation Program
-
SailPoint Announces Date of Fiscal First Quarter 2027 Earnings Conference Call and Investor Day
-
electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia
-
Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
-
Everlert, Inc. (OTC: EVLI), Operating as American Gold & Copper Inc., Announces Closing of Transformative Reverse Merger with South American Gold, Copper, and Silver Project
-
Acronis Introduces Cyber Frame, Addressing Service Provider Demand for Profitable, Reliable, and Protected IaaS
-
Swarmer Awarded $2.86M Contract to Outfit SkyKnight Drones With Swarming Software
-
Third Avenue Management Goes Live on Ridgeline’s AI-Enabled Investment Management Platform
-
New Deloitte White Paper Identifies Canadian Wine Supercluster as $10.1B Economic Growth Engine
-
InnoCare Announce First Subject Dosed in Phase 1 Clinical Trial of ICP-054, a Novel Potentially Best-in-Class Oral IL-17AA/AF Inhibitor
-
MT Højgaard Holding A/S: Major shareholder announcement
-
BlockBooster Joins Canton Foundation as Official Member, Standing Alongside DTCC, Euroclear, BNP Paribas, and HSBC
-
B2BINPAY Secures FSC Mauritius VASP Licenses, Advancing Its Regulated Crypto Payments Strategy
-
Dyne Therapeutics to Participate in Upcoming Investor Conferences
-
Chop Steakhouse & Bar Brings a Modern Steakhouse Experience to South Surrey
-
Nexxen Reports Record First Quarter 2026 Financial Results
-
AGF Investments Announces Final Distribution for AGF Emerging Markets ex China Fund ETF Series
-
BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights
-
Nexxen TV Home Screen Expands with TCL FFALCON and TiVo Ads
-
Rent the Runway, Inc. Announces CEO Transition
-
Electra Awards Solvent Extraction Construction Package
-
BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
-
Palvella Therapeutics Announces Uplisting to the Nasdaq Global Market
-
Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions
-
Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update
-
Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update
-
Beyond Oil Commences Sales With Iconic American Fast-Food Chain
-
PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results
-
MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA
-
Altimmune Announces First Quarter 2026 Financial Results and Business Update
-
Pyxis Oncology to Participate in Upcoming Investor Conferences
-
Dyne Therapeutics to Participate in Upcoming Investor Conferences
-
Battle Born® Launches New E-Commerce Website to Enhance Customer Experience and Support Commercial Growth
-
Kane Biotech Presents Data To Global Wound Care Community at WCET®–NSWOCC® 2026 Joint Congress
-
Workable Launches MCP Server for AI-Powered Recruiting and HR Workflows

